VEON — Direct Digital drives earnings higher

VEON (NASDAQ: VEON)

Last close As at 11/08/2025

USD56.45

0.25 (0.44%)

Market capitalisation

USD4,176m

More on this equity

Research: TMT

VEON — Direct Digital drives earnings higher

VEON delivered a strong Q225, with revenue of $1,087m beating our estimate (3.4%) and underlying EBIT, (stripping out a $498m gain), of $322m, 13.2% ahead of our estimate. We have increased our adjusted EPS estimate by 3.4% to $5.33 in FY25 and 4.9% to $6.63 in FY26, and new reported EPS to $12.39 in FY25 and $6.77 in FY26. Progress towards the listing of Kyivstar has been rapid and, assuming all goes to plan, the deal may complete with the listing achieved during the second week of August. The digital business generated Q2 Direct Digital revenue of $180m, up 56.6% y-o-y, contributing 16.5% of group revenue. VEON estimates FY25 growth of 13–15% (vs 12–14% previously). Our DCF-based valuation generates a fair value of $65.7 (vs $60.1 previously).

Written by

Dan Ridsdale

Head of Technology

Technology

Q225 results

12 August 2025

Price $56.20
Market cap $4,157m

Net cash/(debt) at 30 June 2025

$(3,631.0)m

Shares in issue

72.2m
Code VEON
Primary exchange NASDAQ
Secondary exchange N/A
Price Performance
% 1m 3m 12m
Abs 26.2 17.4 106.6
52-week high/low $59.1 $25.9

Business description

VEON is a frontier market telecommunications company with businesses in Ukraine, Pakistan, Bangladesh, Kazakhstan and Uzbekistan. It offers services ranging from traditional mobile and internet, to sophisticated digital solutions for consumers and businesses.

Next events

Kyivstar listing

Second week of August

Q325 results

10 November 2025

Analysts

Dan Ridsdale
+44 (0)20 3077 5700
Nick Paton
+44 (0)20 3077 5700

VEON is a research client of Edison Investment Research Limited

Note: PBT is normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. EPS is reported (US GAAP). VEON’s shares are only listed on Nasdaq through the ADS structure; all per share data refer to ADS.

Year end Revenue ($m) EBITDA ($m) PBT ($m) EPS ($) DPS ($) P/E (x) Yield (%)
12/23 3,698.0 1,609.0 559.0 (35.99) 0.00 N/A N/A
12/24 4,004.0 1,691.0 704.0 5.87 0.00 9.6 N/A
12/25e 4,271.7 1,910.4 1,134.4 12.39 0.00 4.5 N/A
12/26e 4,497.5 2,048.4 847.9 6.77 3.15 8.3 5.6

Q225 snapshot and catalysts

Q225 revenue was $1,087m (+5.9% y-o-y reported, +11.2% in local currency, LCY) and EBITDA was $520m (+13.2% y-o-y reported, +19.6% LCY), with digital continuing materially to outpace the core. Group Direct Digital revenue was $180m (+56.6% y-o-y), representing 16.5% of the total (vs 11.2% a year ago). Net profit of $608m was boosted by a $498m one-off gain from sale of Jazz’s Pakistan towers business. We update our EPS estimates for FY25–26 to reflect the raised guidance, Uklon consolidation and Pakistan tower benefits. The Kyivstar Nasdaq listing, potentially completing soon after the 12 August Cohen Circle EGM, remains a near-term catalyst alongside further digital scaling.

Kyivstar listing and strategic optionality

Kyivstar’s planned listing via its business combination with Cohen Circle has secured the non-redemption agreements to meet the $50m minimum cash condition. With the EGM on 12 August and management stating it ‘anticipates closing shortly thereafter’, we see scope for listing in the second week of August. Kyivstar continues to execute strongly (Q2 revenue +20.8% y-o-y; EBITDA +18.6% y-o-y), and the April consolidation of Uklon contributed $21.7m in revenue and $9.3m in EBITDA in the Q2. We expect the listing to crystallise a standalone valuation for Kyivstar and sharpen VEON’s capital allocation options.

Valuation and estimate changes

We value VEON using a DCF approach, with explicit FY26–30 forecasts and a terminal value calculated from 2030. Our assumptions include a 16.9% WACC and a 3.5% terminal growth rate. This equates to $65.7/share, a 17% premium to the current price of $56.2. We raise our FY25 net income estimate to $877m (including the $498m gain), FY26 to $479m (+7.0%) and FY27 to $547m (+3.5%) in FY27.

Q225 results: Broad-based beat versus our estimates

VEON delivered strong Q225 results, with performance exceeding our estimates across all major metrics. Group revenue rose by 5.8% y-o-y to $1,087m, coming in 3.4% ahead of our $1,052m forecast, supported by growth across key markets. EBITDA increased by 25.3% y-o-y to $520m, a 15.9% beat versus our estimate, reflecting continued margin expansion from operational efficiencies.

EBIT of $820m was almost triple our $285m forecast, driven by one-off items affecting comparability. On an adjusted basis, EBIT rose 2.9% y-o-y to $322m, 13.2% ahead of our estimate.

At the divisional level, Ukraine posted an 8.4% y-o-y revenue increase to $257m, modestly above our estimates. Pakistan grew 10.9% y-o-y to $386m, while Bangladesh declined by 21.8% to $111m. Kazakhstan revenues fell 16.8% y-o-y to $188m, reflecting continued macroeconomic headwinds, while Uzbekistan rose 9.0% to $73m. EBITDA trends broadly mirrored the top-line performance, with notable growth in Pakistan (+2.5% y-o-y) and Ukraine (+2.1% y-o-y) offsetting weakness in Kazakhstan (-24.0% y-o-y).

The results highlight strong operational momentum, cost discipline and upside surprises across both the top line and profitability, with positive contributions from most major markets.

Financials

Digital acceleration

VEON’s digital operations continue to scale rapidly, with Direct Digital revenue of $180m in Q2, +56.6% y-o-y, and $326m in H1, +53.6% y-o-y, now contributing 16.5% of group revenue. Total digital monthly active users (MAUs) reached 119.7 million, +7.1% y-o-y, with Financial Services MAUs up 27.9% y-o-y to 40.7 million. Within this, Helsi MAUs grew 15.8% y-o-y to 2.5 million and Kyivstar TV MAUs rose 21.7% y-o-y to 2.0 million. The Uklon acquisition strengthens VEON’s mobility offering and adds meaningful scale in Ukraine. We see digital’s trajectory as a core driver of the FY25 guidance upgrade (LCY revenue growth now 13–15% vs 12–14% previously; LCY EBITDA growth 14–16% vs 13–15% previously), supporting our current $60.0/ADS fair value estimate pending a full model refresh.

Positive signal from the SPAC trading

Cohen Circle Acquisition Corp (CCIR), the special purpose acquisition company (SPAC) vehicle facilitating the listing of Kyivstar, closed at a price of $11.46 on 11 August, comfortably above its approximate $10 trust value. We valued the Kyivstar (currently CCIR) shares post-deal and listed, at $10.6 in our note, Catalysts from Kyivstar IPO and buyback, published on 8 July. The fact that the shares are trading above both the trust value and our estimate of Kyivstar’s value per share, signals strong investor confidence in the completion of the transaction and potential upside in Kyivstar’s valuation post-listing. A sustained rally in CCIR shares is not just a reflection of optimism, it is often the market’s way of positioning ahead of a liquidity event, with early momentum feeding into listing day dynamics. We believe Kyivstar may list as early as 15 August, although it is difficult to be certain given the various approvals that may be required; the long stop date is 10 October 2025.

Changes to estimates: Upward revisions across most markets

We have revised our FY25–27 forecasts following the strong Q225 results, with upgrades to group revenue, EBITDA and net income. We now estimate group sales of $4,272m in FY25 (+1.6% vs our previous forecast), rising to $4,498m in FY26 (+3.1%) and $4,711m in FY27 (+3.1%). The upgrades primarily reflect stronger expectations for Ukraine, where FY25e revenues are now 4.7% higher, and Pakistan (+2.7%), partly offset by modest downgrades to Kazakhstan (-3.0%).

At the EBITDA level, we lift our FY25 forecast by 7.5% to $1,910m, with the largest absolute upgrades in Ukraine (+13.2%) and Bangladesh (+28.4%). We increase EBITDA by 5.3% to $2,048m in FY26 and by 3.2% to $2,191m in FY27.

The EBIT line and below now includes the $498m gain related sales of VEON’s towers business in Pakistan, leading to a 48.7% increase in our EBIT estimate to $1,611m, a 68.4% increase in our FY25 PBT estimate to $1,134m and a 140.2% increase in our net income estimate to $877m.

We increase our net income estimates to $479m (+7.0% vs previously) in FY26 and to $547m (+3.5%) in FY27.

Overall, the revisions reflect our increased confidence in VEON’s operational momentum in Ukraine and Pakistan, as well as margin improvements in Bangladesh, partly offset by a more cautious view on Kazakhstan.

Sensitivities

VEON’s share price remains sensitive to a range of strategic, operational, financial and geopolitical factors, with the imminent Kyivstar listing the most material near-term driver. The transaction has the potential to crystallise significant value, but its execution is subject to regulatory approvals, SPAC-related mechanics (including public shareholder redemptions and warrant exercises) and market sentiment. Any delay or adverse change in deal terms could weaken the expected re-rating impact and prolong uncertainty about the group’s valuation structure.

Beyond Kyivstar, VEON’s operations in frontier markets expose it to currency volatility, inflationary pressures and political risk. Together, Ukraine, Pakistan and Bangladesh account for the majority of group EBITDA and each presents unique sensitivities:

  • Ukraine: while Kyivstar has shown exceptional resilience during the war, a resolution of the conflict could materially accelerate growth. Conversely, any escalation would increase operational risk, constrain network expansion and depress investor sentiment.
  • Bangladesh: the recent partial reversal of telecoms tax hikes is a positive step, but the regulatory environment remains unpredictable, and political polarisation could affect consumer demand and investment conditions.
  • Pakistan: currency depreciation and macro volatility remain key risks, although the market’s high digital finance penetration offers structural growth potential.

Financial sensitivities include the group’s relatively high cost of equity (reflected in a WACC of c 17%) and its ability to maintain access to capital markets for refinancing and growth. While net debt has fallen sharply in recent years, VEON’s capital allocation strategy, particularly the balance between buybacks, potential dividends from FY26 and reinvestment in growth, will be closely scrutinised. The asset-light model improves free cash flow generation, but any underperformance in digital services adoption or expansion in average revenue per user would slow deleveraging and capital return capacity.

Longer term, execution risk around the roll-out of multiplay services and the monetisation of non-connectivity digital offerings is significant. While management’s decentralised, innovation-led approach is designed for frontier markets, it relies on sustained local execution, effective brand positioning and robust governance to maintain competitive advantage.

Valuation

DCF-based valuation increases to $65.7 from $60.1

We value VEON using a discounted cash flow (DCF) approach, with explicit forecasts for FY26–30 and a terminal value calculated from 2030 onwards. Our assumptions include a WACC of 16.9%, a terminal growth rate of 3.5% and a terminal free cash flow margin of 25%. This yields a present value of forecast free cash flows (FY26–30) of $4,013m and a present value of terminal value of US$4,897m, resulting in a total enterprise value of $8,910m at 31 December 2025. Adjusting for forecast net debt and minority interests of US$4,264m at the same date, we derive an equity value of $4,746m. Based on 72.2m shares outstanding, this equates to $65.7 per share, a 17% premium to the current price.

General disclaimer and copyright

This report has been commissioned by VEON and prepared and issued by Edison, in consideration of a fee payable by VEON. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2025 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on VEON

View All

Latest from the TMT sector

View All TMT content

Research: Healthcare

Newron Pharmaceuticals — ENIGMA-TRS 1 commences enrolment

Newron Pharmaceuticals has confirmed that enrolment has begun for its registrational ENIGMA-TRS Phase III programme for lead candidate evenamide. The first of two trials for the programme is ENIGMA-TRS 1, an international, one-year, double-blinded, placebo-controlled, pivotal Phase III study. It aims to enrol 600 patients with treatment-resistant schizophrenia (TRS), and a 12-week readout is anticipated from Q426. Patient enrolment has commenced in line with prior guided timelines, and marks a key milestone for Newron’s lead programme. In parallel, Newron is preparing for the second trial, ENIGMA-TRS 2, which will be a 400-patient international study (including the US). This trial is anticipated to launch by October 2025.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free